Technical Analysis for IART - Integra LifeSciences Holdings Corporation

Grade Last Price % Change Price Change
F 28.68 -9.33% -2.95
IART closed down 9.33 percent on Friday, April 19, 2024, on 3.69 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Apr 24
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Down 10% about 10 hours ago
2x Volume Pace about 11 hours ago
Down 2 ATRs about 11 hours ago
60 Minute Opening Range Breakdown about 12 hours ago
1.5x Volume Pace about 12 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Integra LifeSciences Holdings Corporation Description

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Instruments, U.S. Extremities, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery products, including dural repair products, cerebral spinal fluid management devices, tissue ablation equipment, intracranial monitoring equipment, and cranial stabilization equipment. In addition, it provides instruments products, such as specialty and general surgical instruments, dental instruments, and surgical lighting for sale to hospitals and outpatient surgery centers, as well as physician, veterinarian, and dental practices. The company sells its products directly through various sales forces and distribution channels in the United States, Europe, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Plainsboro, New Jersey.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Wound Spine Neurosurgery Ablation Minimally Invasive Procedure Nerve Orthopedic Surgery Orthopedics Surgical Specialties Repair Products Deformity Fluid Management General Surgery Logic Products Spinal Fusion Biologic Products Outpatient Surgery Stryker Corporation Biologic Product Dental Instruments Generation Products Surgical Instruments Invasive Solutions

Is IART a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.05
52 Week Low 27.8501
Average Volume 790,222
200-Day Moving Average 39.92
50-Day Moving Average 36.92
20-Day Moving Average 33.32
10-Day Moving Average 32.52
Average True Range 1.09
RSI (14) 19.35
ADX 39.3
+DI 9.41
-DI 50.38
Chandelier Exit (Long, 3 ATRs) 32.21
Chandelier Exit (Short, 3 ATRs) 31.13
Upper Bollinger Bands 36.29
Lower Bollinger Band 30.35
Percent B (%b) -0.28
BandWidth 17.84
MACD Line -1.53
MACD Signal Line -1.30
MACD Histogram -0.2283
Fundamentals Value
Market Cap 2.24 Billion
Num Shares 78.2 Million
EPS 1.22
Price-to-Earnings (P/E) Ratio 23.51
Price-to-Sales 2.15
Price-to-Book 2.10
PEG Ratio 1.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.48
Resistance 3 (R3) 34.85 33.29 33.52
Resistance 2 (R2) 33.29 31.81 33.10 33.19
Resistance 1 (R1) 30.98 30.90 30.20 30.61 32.87
Pivot Point 29.42 29.42 29.03 29.23 29.42
Support 1 (S1) 27.11 27.94 26.33 26.75 24.49
Support 2 (S2) 25.55 27.03 25.36 24.17
Support 3 (S3) 23.24 25.55 23.84
Support 4 (S4) 22.88